• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.

作者信息

Gentile Ivan, Buonomo Antonio Riccardo, Maraolo Alberto Enrico, Scotto Riccardo, De Zottis Federico, Di Renzo Gianfranco, Borgia Guglielmo

机构信息

Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples 'Federico II', Naples, Italy.

Department of Neuroscience, Reproductive and Odontostomatological Sciences, Division of Pharmacology, University of Naples 'Federico II', Naples, Italy.

出版信息

J Antimicrob Chemother. 2017 Sep 1;72(9):2678-2679. doi: 10.1093/jac/dkx172.

DOI:10.1093/jac/dkx172
PMID:28575437
Abstract
摘要

相似文献

1
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy.用头孢他啶/他唑巴坦单药成功治疗由广泛耐药铜绿假单胞菌引起的术后骨髓炎。
J Antimicrob Chemother. 2017 Sep 1;72(9):2678-2679. doi: 10.1093/jac/dkx172.
2
Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration.在接受连续性静脉-静脉血液透析滤过的重症患者中使用头孢洛扎/他唑巴坦治疗多重耐药铜绿假单胞菌。
Int J Antimicrob Agents. 2016 Sep;48(3):342-3. doi: 10.1016/j.ijantimicag.2016.06.005. Epub 2016 Jul 8.
3
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.成功使用头孢洛扎/他唑巴坦治疗由多重耐药铜绿假单胞菌引起的囊性纤维化肺部加重期
Pharmacotherapy. 2016 Oct;36(10):e154-e159. doi: 10.1002/phar.1825. Epub 2016 Sep 1.
4
Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa: clinical and microbiological outcomes.头孢洛扎/他唑巴坦治疗广泛耐药铜绿假单胞菌引起的骨髓炎和皮肤软组织感染：临床和微生物学结局。
Int J Antimicrob Agents. 2018 Mar;51(3):498-502. doi: 10.1016/j.ijantimicag.2017.11.003. Epub 2017 Nov 20.
5
Ceftolozane/Tazobactam Therapy of Respiratory Infections due to Multidrug-Resistant Pseudomonas aeruginosa.头孢洛扎/他唑巴坦治疗多重耐药铜绿假单胞菌引起的呼吸道感染
Clin Infect Dis. 2015 Sep 1;61(5):853-5. doi: 10.1093/cid/civ411. Epub 2015 May 28.
6
Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.成功治疗三例严重耐多药或广泛耐药铜绿假单胞菌感染的头孢他啶/他唑巴坦。
Future Microbiol. 2017 Nov;12:1323-1326. doi: 10.2217/fmb-2017-0018. Epub 2017 Oct 5.
7
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).头孢洛扎/他唑巴坦对亚太地区（不包括中国、澳大利亚和新西兰）引起的医疗保健相关感染的耐药肠杆菌科和铜绿假单胞菌的活性：来自抗菌监测计划（2013-2015 年）的报告。
Int J Antimicrob Agents. 2018 Feb;51(2):181-189. doi: 10.1016/j.ijantimicag.2017.09.016. Epub 2017 Oct 6.
8
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactam.头孢洛扎/他唑巴坦成功治疗多重耐药铜绿假单胞菌皮肤及软组织感染。
J Glob Antimicrob Resist. 2017 Jun;9:100-102. doi: 10.1016/j.jgar.2017.02.012. Epub 2017 May 8.
9
Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation.头孢他啶-他唑巴坦耐药铜绿假单胞菌的出现是由单个 AmpC 结构突变介导的。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01183-17. Print 2017 Dec.
10
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).针对2011 - 12年在欧洲医院分离出的具有不同耐药模式的铜绿假单胞菌和肠杆菌科细菌测试头孢洛扎/他唑巴坦的抗菌活性。
J Antimicrob Chemother. 2014 Oct;69(10):2713-22. doi: 10.1093/jac/dku184. Epub 2014 Jun 10.

引用本文的文献

1
Real-world use of ceftolozane/tazobactam: a systematic literature review.真实世界中头孢他啶/他唑巴坦的应用：系统文献回顾。
Antimicrob Resist Infect Control. 2021 Apr 8;10(1):68. doi: 10.1186/s13756-021-00933-8.
2
Outpatient Parenteral Antimicrobial Therapy With Ceftolozane/Tazobactam via Continuous Infusion for Multidrug-Resistant Osteomyelitis.通过持续输注使用头孢洛扎/他唑巴坦进行门诊胃肠外抗菌治疗耐多药骨髓炎
Open Forum Infect Dis. 2020 Sep 15;7(11):ofaa409. doi: 10.1093/ofid/ofaa409. eCollection 2020 Nov.
3
Ceftolozane-tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series.
头孢洛扎坦-他唑巴坦治疗多重耐药病原体引起的骨髓炎：病例系列
Ther Adv Drug Saf. 2019 Jul 8;11:2042098619862083. doi: 10.1177/2042098619862083. eCollection 2019.
4
Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon?多重耐药性铜绿假单胞菌感染：难以治疗，但曙光在望？
Curr Infect Dis Rep. 2018 Jun 6;20(8):23. doi: 10.1007/s11908-018-0629-6.
5
Treatment of a complex orthopaedic infection due to extensively drug-resistant .由广泛耐药菌引起的复杂骨科感染的治疗
BMJ Case Rep. 2018 Jan 5;2018:bcr-2017-223202. doi: 10.1136/bcr-2017-223202.
6
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant.头孢洛扎/他唑巴坦治疗耐多药铜绿假单胞菌左心室辅助装置感染作为心脏移植的桥接。
Infection. 2018 Apr;46(2):263-265. doi: 10.1007/s15010-017-1086-0. Epub 2017 Oct 31.